Transition Agreements in the Pharmaceuticals Industry

77 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Transition Services Agreement, dated as of January 3, 2025, by and between NovaBay Pharmaceuticals, Inc. and Phase One Health, LLC
Transition Agreements
NovaBay Pharmaceuticals, Inc.
Pharmaceuticals
2025
Transition Agreement between Terns, Inc. and Mark Vignola dated July 23, 2024
Transition Agreements
Terns Pharmaceuticals, Inc.
2024
Transition Agreement and Release by and between Loretta Itri and Aadi Bioscience, Inc., dated September 16, 2024
Transition Agreements
Aerpio Pharmaceuticals, Inc.
2024
Transition Agreement and Release by and between Neil Desai and Aadi Bioscience, Inc., dated October 16, 2024
Transition Agreements
Aerpio Pharmaceuticals, Inc.
2024
Transition Agreement, dated as of July 7, 2024, by and between the Registrant and Paul R. Edick
Transition Agreements
Xeris Biopharma Holdings, Inc.
2024
Transition Agreement, effective January 11, 2024, by and between BioTe Medical, LLC and Samar Kamdar
Transition Agreements
Haymaker Acquisition Corp. III
2024
Executive Transition Agreement dated January 5, 2024
Transition Agreements
Athira Pharma, Inc.
2024
Amendment to the Amended and Restated Transition Agreement, dated January 1, 2024, between SIGA Technologies, Inc. and Phillip Louis Gomez, III
Transition Agreements
SIGA TECHNOLOGIES INC
2024
Transition and Release of Claims Agreement, between Columbia Care Inc. and Rosemary Mazanet, dated August 31, 2023
Transition Agreements
Columbia Care Inc.
2023
Transition Service Agreement by and between Amphastar Pharmaceuticals, Inc., and Eli Lilly and Company, dated June 30, 2023
Transition Agreements
Amphastar Pharma
2023
Transition and Advisory Agreement and Release, dated May 19, 2023, by and between Viatris Inc. and Robert J. Coury
Transition Agreements
Upjohn Inc
2023
Amended and Restated Transition Agreement, dated July 26, 2023, between SIGA Technologies, Inc. and Phillip Louis Gomez, III
Transition Agreements
SIGA TECHNOLOGIES INC
2023
Transition Services Agreement between the Company and Glenna Mileson, dated as of May 18, 2023
Transition Agreements
Athira Pharma, Inc.
2023
Transition Agreement, dated as of May 6, 2023, between Zevra Therapeutics, Inc. and Richard W. Pascoe
Transition Agreements
KEMPHARM, INC
2023
Notice of Resignation and Transition Agreement, effective February 20, 2023, between CymaBay Therapeutics, Inc. and Dennis Kim
Transition Agreements
CymaBay Therapeutics, Inc.
Pharmaceuticals
2023
Transition and Support Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp
Transition Agreements
Zomedica Pharmaceuticals Corp.
Pharmaceuticals
2023
Transition Agreement, dated January 13, 2023, between SIGA Technologies, Inc. and Phillip Louis Gomez, III
Transition Agreements
SIGA TECHNOLOGIES INC
Pharmaceuticals
NY
2023
Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D
Transition Agreements
KEMPHARM, INC
Pharmaceuticals
2023
Transition agreement, effective August 31, 2022, by and between BioTE Medical, LLC and Robbin Gibbins
Transition Agreements
Haymaker Acquisition Corp. III
Pharmaceuticals
2022
Executive Employment and Transition Agreement, dated May 11, 2022, by and among Horizon Therapeutics Public Limited Company, Horizon Therapeutics USA, Inc. and Paul W. Hoelscher
Transition Agreements
Horizon Pharma plc
Pharmaceuticals
IL
2022
Transition Services Agreement, dated July 22, 2022, by and between CURE Pharmaceutical and Buyer
Transition Agreements
Cure Pharmaceutical Holding Corp.
Pharmaceuticals
CA
2022
Transition Agreement, dated November 1, 2021, between Provention and Andrew Drechsler
Transition Agreements
Provention Bio, Inc.
Pharmaceuticals
2022
Confidential Employment Transition Plan and General Release Agreement, dated November 12, 2021
Transition Agreements
Evofem Biosciences, Inc.
Pharmaceuticals
CA
2021
Transition Agreement between the Registrant and R. Don Elsey dated as of September 12, 2021
Transition Agreements
Lyra Therapeutics, Inc.
Pharmaceuticals
MA
2021
Transition Services Agreement, dated as of June 2, 2021, by and between Merck & Co., Inc. and Organon & Co
Transition Agreements
Organon & Co.
Pharmaceuticals
NY
2021
Transition Services Agreement, dated as of June 2, 2021, by and between Merck & Co., Inc. and Organon & Co
Transition Agreements
Organon & Co.
Pharmaceuticals
NY
2021
Termination and Transition Agreement between Aytu BioPharma, Inc. and Acerus Pharmaceuticals Corporation, dated March 31, 2021
Transition Agreements
AYTU BIOSCIENCE, INC
Pharmaceuticals
NY
2021
Amendment to Transition Services Agreement, entered into on April 1, 2021, by and between Aerpio Pharmaceuticals, Inc. and Kevin G. Peters
Transition Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
2021
Transition Services Agreement, entered into on February 9, 2021, by and between Aerpio Pharmaceuticals, Inc. and Kevin Peters
Transition Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Transition Services Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Service Provider) and Pfizer Inc. (as Service Recipient)
Transition Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Transition Services Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Service Provider) and Upjohn Inc. (as Service Recipient)
Transition Agreements
Upjohn Inc
Pharmaceuticals
DE
2020
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Therapeutics, Inc. and Anil Singhal
Transition Agreements
resTORbio, Inc.
Pharmaceuticals
2020
*** Certain identified information hasbeen omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrantif publicly...
Transition Agreements
Adamis Pharmaceuticals Corp
Pharmaceuticals
NY
2020
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Bio, Inc. and Anil Singhal
Transition Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Transition Agreement between Innoviva, Inc. and Geoffrey L. Hulme, dated June 11, 2020
Transition Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2020
Amendment to Transition and Termination Agreement, dated as of March 31, 2020, by and between Jazz Pharmaceuticals, Inc. and Michael Miller
Transition Agreements
Jazz Pharmaceuticals plc
Pharmaceuticals
2020
Transition Services Agreement and General Release
Transition Agreements
ACELRX PHARMACEUTICALS INC
Pharmaceuticals
CA
2020
Transition Agreement by and among Assertio Therapeutics, Inc. and Arthur Higgins, dated as of March 16, 2020
Transition Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
IL
2020
Transition Services Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc
Transition Agreements
Baudax Bio, Inc.
Pharmaceuticals
2019
Transition Services Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc
Transition Agreements
Recro Pharma, Inc.
Pharmaceuticals
2019
Transition and Termination Agreement, dated as of November 2, 2019, by and between Jazz Pharmaceuticals, Inc. and Mike Miller
Transition Agreements
Jazz Pharmaceuticals plc
Pharmaceuticals
2019